CPRX logo

Catalyst Pharmaceuticals (CPRX) Accounts payable

annual accounts payable:

$16.59M+$1.80M(+12.15%)
December 31, 2024

Summary

  • As of today (July 1, 2025), CPRX annual accounts payable is $16.59 million, with the most recent change of +$1.80 million (+12.15%) on December 31, 2024.
  • During the last 3 years, CPRX annual accounts payable has risen by +$13.82 million (+499.46%).
  • CPRX annual accounts payable is now at all-time high.

Performance

CPRX Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

quarterly accounts payable:

$11.20M-$5.40M(-32.52%)
March 31, 2025

Summary

  • As of today (July 1, 2025), CPRX quarterly accounts payable is $11.20 million, with the most recent change of -$5.40 million (-32.52%) on March 31, 2025.
  • Over the past year, CPRX quarterly accounts payable has increased by +$936.00 thousand (+9.12%).
  • CPRX quarterly accounts payable is now -32.52% below its all-time high of $16.59 million, reached on December 31, 2024.

Performance

CPRX quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

CPRX Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+12.2%+9.1%
3 y3 years+499.5%+117.9%
5 y5 years+303.0%+730.9%

CPRX Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+499.5%-32.5%+383.7%
5 y5-yearat high+499.5%-32.5%+458.4%
alltimeall timeat high>+9999.0%-32.5%>+9999.0%

CPRX Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$11.20M(-32.5%)
Dec 2024
$16.59M(+12.2%)
$16.59M(+43.5%)
Sep 2024
-
$11.56M(+62.5%)
Jun 2024
-
$7.12M(-30.7%)
Mar 2024
-
$10.26M(-30.6%)
Dec 2023
$14.79M(+272.2%)
$14.79M(+221.8%)
Sep 2023
-
$4.60M(+4.0%)
Jun 2023
-
$4.42M(+30.4%)
Mar 2023
-
$3.39M(-14.7%)
Dec 2022
$3.98M(+43.6%)
$3.98M(+57.2%)
Sep 2022
-
$2.53M(+9.2%)
Jun 2022
-
$2.31M(-55.0%)
Mar 2022
-
$5.14M(+85.7%)
Dec 2021
$2.77M(-35.0%)
$2.77M(+0.6%)
Sep 2021
-
$2.75M(-5.9%)
Jun 2021
-
$2.92M(+14.2%)
Mar 2021
-
$2.56M(-39.8%)
Dec 2020
$4.26M(+3.4%)
$4.26M(+112.2%)
Sep 2020
-
$2.01M(-65.5%)
Jun 2020
-
$5.80M(+330.8%)
Mar 2020
-
$1.35M(-67.3%)
Dec 2019
$4.12M(+76.2%)
$4.12M(-0.7%)
Sep 2019
-
$4.15M(+24.6%)
Jun 2019
-
$3.33M(+13.2%)
Mar 2019
-
$2.94M(+25.8%)
Dec 2018
$2.34M(+20.1%)
$2.34M(+74.3%)
Sep 2018
-
$1.34M(+45.4%)
Jun 2018
-
$922.60K(+14.6%)
Mar 2018
-
$805.00K(-58.6%)
Dec 2017
$1.95M(+108.5%)
$1.95M(+79.9%)
Sep 2017
-
$1.08M(+56.2%)
Jun 2017
-
$692.30K(-24.6%)
Mar 2017
-
$917.90K(-1.6%)
Dec 2016
$933.20K(-48.0%)
$933.20K(-11.6%)
Sep 2016
-
$1.06M(+49.2%)
Jun 2016
-
$707.30K(-43.5%)
Mar 2016
-
$1.25M(-30.2%)
Dec 2015
$1.79M
$1.79M(+119.6%)
Sep 2015
-
$817.00K(-37.9%)
DateAnnualQuarterly
Jun 2015
-
$1.32M(+25.3%)
Mar 2015
-
$1.05M(-42.1%)
Dec 2014
$1.81M(+113.2%)
$1.81M(+245.7%)
Sep 2014
-
$524.80K(-57.6%)
Jun 2014
-
$1.24M(+32.8%)
Mar 2014
-
$932.10K(+9.6%)
Dec 2013
$850.80K(-37.7%)
$850.80K(-42.3%)
Sep 2013
-
$1.47M(+228.6%)
Jun 2013
-
$448.30K(-21.0%)
Mar 2013
-
$567.20K(-58.5%)
Dec 2012
$1.37M(+417.5%)
$1.37M(+283.7%)
Sep 2012
-
$355.90K(+59.6%)
Jun 2012
-
$223.00K(-36.3%)
Mar 2012
-
$350.30K(+32.7%)
Dec 2011
$263.90K(+149.2%)
$263.90K(+51.7%)
Sep 2011
-
$174.00K(-63.6%)
Jun 2011
-
$478.00K(+12.4%)
Mar 2011
-
$425.40K(+301.7%)
Dec 2010
$105.90K(-57.6%)
$105.90K(-56.1%)
Sep 2010
-
$241.30K(-4.2%)
Jun 2010
-
$252.00K(+185.4%)
Mar 2010
-
$88.30K(-64.6%)
Dec 2009
$249.60K(-25.0%)
$249.60K(+53.0%)
Sep 2009
-
$163.10K(-40.8%)
Jun 2009
-
$275.70K(-62.6%)
Mar 2009
-
$737.60K(+121.7%)
Dec 2008
$332.70K(+51.3%)
$332.70K(-47.7%)
Sep 2008
-
$635.60K(+250.6%)
Jun 2008
-
$181.30K(-42.7%)
Mar 2008
-
$316.60K(+44.0%)
Dec 2007
$219.90K(-50.9%)
$219.90K(-4.2%)
Sep 2007
-
$229.50K(+56.8%)
Jun 2007
-
$146.40K(-53.2%)
Mar 2007
-
$312.50K(-30.3%)
Dec 2006
$448.10K(+560.9%)
$448.10K(+7.3%)
Sep 2006
-
$417.80K(+1577.9%)
Jun 2006
-
$24.90K(-63.3%)
Dec 2005
$67.80K(+120.8%)
$67.80K(+120.8%)
Dec 2004
$30.70K
$30.70K

FAQ

  • What is Catalyst Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals annual accounts payable year-on-year change?
  • What is Catalyst Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals quarterly accounts payable year-on-year change?

What is Catalyst Pharmaceuticals annual accounts payable?

The current annual accounts payable of CPRX is $16.59M

What is the all time high annual accounts payable for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high annual accounts payable is $16.59M

What is Catalyst Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, CPRX annual accounts payable has changed by +$1.80M (+12.15%)

What is Catalyst Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of CPRX is $11.20M

What is the all time high quarterly accounts payable for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high quarterly accounts payable is $16.59M

What is Catalyst Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, CPRX quarterly accounts payable has changed by +$936.00K (+9.12%)
On this page